-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, antibodies, anticoagulant drugs, apheresis, Biological, Coronaviruses, HSCs, Leukemia, SARS-CoV-2/COVID-19, survivorship, viral, bacterial, Bleeding and Clotting, bone marrow, Diseases, neurotoxicity, Non-Biological, Combinations, thalassemia, Therapies, Adverse Events, chemotherapy, MDS, Pediatric, Biological Processes, Hemoglobinopathies, Technology and Procedures, Young Adult, Cell Lineage, immunotherapy, Infectious Diseases, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , Thrombotic Disorders, transplantation, inflammation
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Kayla Madsen, NP1*, Gabrielle Cote, MD2,3*, Karyne Pelletier, MD2,3*, Abhijat Kitchlu, MD, MSc2,3*, Shiyi Chen, MSc4*, Jonas Mattsson, MD3,5* and Ivan Pasic, MD, PhD3,4*

1Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Division of Nephrology, University Health Network, Toronto, Canada
3Department of Medicine, University of Toronto, Toronto, Canada
4Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
5Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada

Akinao Okamoto1*, Yoshinobu Kanda, MD, PhD2, Shun-Ichi Kimura, MD3*, Tatsuo Oyake, MD, PhD4* and Kazuo Tamura, MD, PhD5*

1Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan
2Jichi Medical Univ., Saitama, Japan
3Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
4Division of Hematology and Oncology, Department of Internal Medicine, Internal Medicine Iwate Medical University, Morioka, Japan
5Research Promotion Division, Fukuoka University, Fukuoka, Japan

Yuhua Xiao1*, Xiaoqin Feng1*, Yuelin He, MD1* and Chunfu Li, MD2,3

1Department of Pediatrics, Nanfang Hospital,Southern Medical University, Guangzhou, China
2Department of Pediatrics, Nanfang Hospital,Southern Medical University, Guangzhou, Guangdong, China
3Nanfang-Chunfu Children's Institute of Hematology & Oncology, Dongguan, China

Karen Sweiss, PharmD1, Eric Wenzler2*, Hung H Nguyen, MLS3*, Avadhut D Joshi, PhD3*, Rosa Yeh, PharmD3*, Gregory Sampang Calip, PharmD, MPH, PhD4*, Jeremy Johnson, PharmD, PhD5*, Donald Irby, PhD6*, Mitch A. Phelps, PhD7*, Damiano Rondelli, MD8 and Pritesh Patel, MB, ChB8

1Department of Pharmacy Practice, University of Illinois, Hinsdale, IL
2University of Illinois At Chicago, Chicago, IL
3Seattle Cancer Care Alliance, Seattle, WA
4Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL
5Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
6Ohio State University College of Pharmacy, Columbus, OH
7College of Pharmacy, The Ohio State University, Columbus, OH
8Division of Hematology/Oncology, University of Illinois, Chicago, IL

Steven J Kovacs1*, Johanna R Abend2*, Xiaoying Xu1*, Sachin Desai1*, Amanda Nguyen1*, Laura M Sterling3*, Michael R Hodges4* and Peter Pertel1*

1Novartis Institutes for BioMedical Research, Translational Medicine, East Hanover, NJ
2Novartis Institutes for BioMedical Research, Infectious Disease Area, Emeryville, CA
3Celerion, Lincoln, NE
4Amplyx Pharmaceuticals, Inc, San Diego, CA

Betul Oran, MD, MS1, Stefan O. Ciurea, MD2, Rohtesh S. Mehta, MD, MPH, MS3, Amin M. Alousi, MD4, Gabriela Rondon2, Uday R. Popat, MD3, David Marin2, May Daher3, Jin S. Im3, Partow Kebriaei, MD2, Gheath Alatrash2 and Richard E. Champlin, MD2

1Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX

Eleni Gavriilaki, MD1, Chrysavgi Lalayanni2*, Ioanna Sakellari, MD PhD1*, Christos Varelas, MD, MSc3*, Despina Mallouri1*, Ioannis Batsis2*, Anna Vardi, MD, PhD4*, Sofia Tagara5*, Marianna Masmanidou6*, Maria Papathanasiou7*, Lila Papalexandri, MD2*, Chrysanthi Vadikoliou8*, Anastasia Athanasiadou, MD PhD9* and Achilles Anagnostopoulos10

1Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
2Hematology Department - HCT Unit, George Papanikolaou Hospital, Thessaloniki, Greece
3G Papanicolaou Hospital, Exochi, Thessaloniki, GRC
4Department of Hematology and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
5G Papanicolaou Hospital, 57010, Greece
6Hematology Department - BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
7G. PAPANICOLAOU HOSPITAL, THESSALONIKI, Greece
8Hematology Department - BMT Unit, George Papanikolaou Hospital, Thessaloniki, ATTIKA, Greece
9Hematology Department - BMT Unit, George Papanikolaou Hospital, Thessaloniki, GRC
10George Papanicolaou Hospital, Thessaloniki, Greece

Qianhuang Ian Q Wu, MBBS1, Yeh Ching Linn, MBBS, MRCP2*, William YK Hwang, MBBS2,3, Michelle Poon, MBBS, MRCP, FRCPATH4*, Lip Kun Tan, MBBS, FRCP, FRCPath5*, Yang Liang Boo, MD5*, Yeow Tee Goh, MBBS2, Aloysius YL Ho, MBBS, FRCP, FRCPath2 and Liang Piu Koh, MBBS, MRCP5*

1National University Cancer Institute, Singapore, Singapore
2Department of Hematology, Singapore General Hospital, Singapore, Singapore
3National Cancer Center Singapore, Singapore, Singapore
4Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
5Department of Haematology­-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore

Mary Nauffal, MS, PharmD1*, Haesook T. Kim, PhD2, Paul G. Richardson, MD2, Robert J. Soiffer, MD3, Joseph H. Antin, MD4, Corey Cutler, MD, MPH, FRCPC 5, Sarah Nikiforow, MD, PhD2, Mahasweta Gooptu, MD4, John Koreth, MBBS, DPhil2, Roman M Shapiro, MD6, Rizwan Romee, MD2,4 and Vincent T. Ho, MD6*

1Department of Pharmacy, Brigham and Women's Hospital, Brookline, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
5Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Vinodhini M, MD, DM1,2*, Anant Gokarn, MD, DM1,2*, Sachin Punatar1,2*, Sumeet Prakash Mirgh, MD, DM1,2*, Akanksha Chichra, DNB1,2*, Vijay Shirure, MD, DM1,2*, Avinash Bonda, MD, DM1,2*, Lingaraj Nayak, MD, DM1,2*, Bhausaheb Bagal, MD, DM1,2*, Vivek Bhat, MD2,3*, Sanjay Biswas, MD2,3*, Sadhana Kannan, MSc2,4*, Libin J Mathew1,2*, Rachana Tripathi5*, Shesheer Kumar5*, Tapan Saikia, MD6 and Navin Khattry, MD, DM1,2*

1Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre., Navi Mumbai., India
2Homi Bhabha National Institute., Mumbai., India
3Tata Memorial Centre., Department of Microbiology., Mumbai., India
4Tata Memorial Centre., Department of biostatistics., Navi Mumbai., India
5Huwel Lifesciences Pvt. Ltd., Hyderabad., India
6Prince Aly Khan Hospital, Mumbai, India

Richi Kashyap, MD1*, Muhammad Ashar Ali, MD2*, Taaha Muddassir Mirza, MBBS3*, Anum Javaid, MD3*, Aniqa Raheem, MBBS4*, Rohail Gul, MBBS5*, Muhammad Tayyeb, MD6*, Muhammad Yasir Anwar2*, Abdul Jabbar Dar, MD7*, Qasim Khurshid, MD8*, Karun Neupane, MBBS, MD9* and Faiz Anwer, MD10

1Maulana Azad Medical College, New Delhi, India
2King Edward Medical University, Lahore, Pakistan
3Rawalpindi Medical University, Rawalpindi, Pakistan
4Shalamar Medical and Dental College, Lahore, Pakistan
5Shifa College of Medicine, Islamabad, Pakistan
6Department of internal medicine, King Edward Medical University, Lahore, Pakistan
7Shaikh Zayed Medical College, Lahore, Pakistan
8Xinjiang Medical University, Urumqi, China
9Manipal College of Medical Sciences, Pokhara, Nepal
10Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Ashvind Anand Prabahran, MBBS1,2,3*, James Anton Kuzich, MBBS1, Andrew B M Lim, MBBS, FRACP, FRCPA4, Eric Wong, MD, PhD, FRACP, FRCPA1,3* and David Ritchie, MB ChB, PhD, FRACP, FRCPA1,2,3

1Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
2The University of Melbourne, Parkville, VIC, Australia
3ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Melbourne, VIC, Australia
4Department of Haematology and Medical Oncology, Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Heidelberg, VIC, Australia

Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn*

Department of Pediatrics, Jena University Hospital, Jena, Germany

Jinhua Ren1*, Dabing Chen1*, Rong Zheng1*, Yu Zhang1*, Jingjing Xu1*, Xiaofeng Luo1*, Zhihong Zheng1*, Zhizhe Chen1*, Jianda Hu, MD, PhD2 and Ting Yang, MD, PhD3

1Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2Fujian Medical University Union Hospital, Fuzhou, China
3Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China

Archana Ramgopal, DO1, James Zullo2*, Jignesh Dalal, MD3, Meghan McCormick, MD4 and Ram Kalpatthi, MD5

1UPMC, Department of Pediatrics, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
2UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
3Rainbow Babies & Children's Hospital, Cleveland, OH
4Department of Pediatric Hematology/Oncology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
5Department of Pediatric Hematology/Oncology, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA

Fumiya Wada1*, Yasuyuki Arai, MD, PhD1, Junya Kanda, MD, PhD2, Toshio Kitawaki, MD, PhD2*, Masakatsu Hishizawa, MD, PhD2*, Tadakazu Kondo, MD, PhD2, Kouhei Yamashita, MD, PhD2 and Akifumi Kondo Takaori, MD, PhD2*

1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, KYO, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Annalisa Paviglianiti1*, Simona Sestili2*, Antonio Bianchessi, MD2,3*, Eolia Brissot, MD, PhD4*, Mara Memoli2,5*, Remy Duléry6,7*, Anne Banet8*, Zoe Van De Wyngaert6*, Ramdane Belhocine6*, Tounes Ledraa4*, Florent Malard, MD, PhD9,10* and Mohamad Mohty11,12

1Service d'Hématologie Clinique et Thérapie Cellulaire, Eurocord, Hopital Saint Louis, Paris, France
2Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
3Department of Molecular Medicine & Hematology Oncology, University of Pavia & IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
4Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France, Paris, France
5Department of Medicine and Surgery, Hematology and Hematopoietic Stem Cell Transplant Center, University of Naples Federico II, Napoli, Italy
6Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France
7Centre de Recherche Saint-Antoine Inserm UMRs938, AP-HP.Sorbonne University, Paris, France
8Service d'Hématologie Clinique et Thérapie Cellulaire, Sorbonne Université, INSERM UMRs 938,, Paris, FRA
9Service d'Hématologie Clinique et de Thérapie Cellulaire, Hopital Saint Antoine, Paris, France
10Sorbonne Universités, Université Pierre et Marie Curie, Centre de Recherche Saint-Antoine Inserm U938, Paris, France
11Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France, Paris, France
12Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France, Paris, France

Olesia V Paina, PhD1*, Zhemal Zarifovna Rakhmanova, Dr.1*, Polina Valerievna Kozhokar, Dr.1*, Anastasia S Frolova, Dr1*, Liubov A. Tsvetkova, tsvetluibov@mail.ru2*, Kirill Alexandrovich Ekushov, Dr.1*, Inna Markova1*, Sergey N. Bondarenko1*, Elena V. Babenko1*, Aleksandr L. Alyanskiy, aalyanskiygmail.com2*, Ildar M Barkhatov, MD, PhD1*, Elena Vladimirovna Semenova, PhD3*, Aleksandr D. Kulagin, MD, PhD1*, Ivan S. Moiseev1* and Ludmila S Zubarovskaya, MD, PhD, professor1*

1RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
2RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
3RM Gorbacheva Research Institute, Pavlov University, Saint-Petrsburg, Russia

Tom Dunne, B.Comm (Hons), MD1 and David M. Jones, MD2*

1University of Calgary, Calgary, AB, Canada
2Division of Hematology, St John's, NL, CAN

Saad Javed, MD1*, Tariq Iqtidar Sadiq Syed, MD2*, Hejab Fatima, MBBS3*, Syed Hashim Ali Inam, MBBS4*, Tayyab Rehan, MBBS5*, Syed Maaz Abdullah, MBBS6*, Mohammed Musa Najmuddin, MBBS3*, Mobeen Zaka Haider, MD, MBBS7*, Karun Neupane, MBBS, MD8*, Muhammad Khawar Sana, MD9*, Abdul Jabbar Dar, MD10*, Ali Jaan, MD11*, Muhammad Ali Mirza, MD12* and Faiz Anwer, MD13

1Department of Internal Medicine, Allama Iqbal Medical College, Lahore, Pakistan
2Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, bronx, NY
3Allama Iqbal Medical College, Lahore, Pakistan
4Internal Medicine, Army Medical College, Rawalpindi, Pakistan
5Nishtar Medical University, Multan, Pakistan
6King Edward Medical University, Lahore, Punjab, Pakistan
7King Edward Medical University, Sartell, MN
8Manipal College of Medical Sciences, Pokhara, Nepal
9Department of Internal Medicine, King Edward Medical University, Lahore, AL, Pakistan
10Shaikh Zayed Medical College, Lahore, Pakistan
11King Edward Medical University, Lahore, Pakistan
12Department of Medicine, Frontier Medical And Dental College, Abbottabad, ON, Pakistan
13Department of Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Moreland Hills, OH

Sajjad Hassan1*, Kamille West, MD2*, William Ward2*, Jennifer A Kanakry3,4* and Willy A. Flegel, MD2,5

1Department of Transfusion Medicine, National Institutes of Health, Rockville, MD
2Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD
3Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD
4Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD

Per Ljungman, MD, PhD1, Rafael De La Camara, MD2, Malgorzata Mikulska3*, Gloria Tridello4*, Beatriz Aguado, MD5*, Yves Beguin, MD, PhD6*, Rodrigo Martino Bufarull7*, Fabio Ciceri, MD8*, Lucía López Corral, MD9*, Claudia Crippa, MD10*, Dries Deeren, MD, PhD11, Rafael F. Duarte, MD, PhD, FRCP12, María Laura Fox13*, Anna Grassi, MD14*, María-José Jimenez, MD15*, Safiye Koculu, MD16*, Mi Kwon, MD, PhD17*, Juan Carlos Vallejo Llamas18*, Jose Luiz Lopez Lorenzo, MD19*, Stephan Mielke, MD20,21, Javier López Jiménez, MD, PhD22*, Zoraida Mesa Morales23*, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath24, Rocio Parody Porras25*, Victoria Potter, MBBS, BSc, FRACP, FRCPA26*, María Suárez-Lledó, MD27*, Nicolaas Schaap, MD, PhD28, Celestine Simand, MD29*, Luisa Sisinni, MD30*, John A Snowden, MD, PhD31*, Daniele Vallisa, MD32, Ipek Yonalhindilerden33*, Alienor Xhaard, MD34*, Nina Simone Knelange35*, Angel Cedillo36*, Nicolaus Kröger, MD37*, Jose Luis Piñana Sanchez38* and Jan Styczynski, MD, PhD39

1Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, SWE
2Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain
3Division of Infectious Diseases, University of Genova, Ospedale Policlinco San Martino, Genova, Italy
4Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
5Hospital Universitario de La Princesa, Madrid, Spain
6Department of Hematology, University of Liege, Liege, Belgium
7Hospital Santa Creu i Sant Pau, Barcelona, Spain
8Haematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
9Hospital Clínico, Servicio de Hematología, Salamanca, Spain
10Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
11Algemeen Ziekenhuis (AZ) Delta, Roeselare, Belgium
12Hematopoietic Transplantation and Hemato-oncology Section, Institut Català d'Oncologia Hospital Duran i Reynals, Madrid, Spain
13Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron. Barcelona, Spain, Barcelona, Spain
14ASST Papa Giovanni XXIII, Bergamo, ITA
15Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona, Spain
16HSCT Unit, Demiroglu Bilim University, Istanbul, Turkey
17Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
18University Hospital Donostia, San Sebastian, Spain
19Servicio de Hematología y Hemoterapia, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
20Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Stockholms Laen, Sweden
21Department of Laboratory Medicine, Department of Cell Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska Institute and University Hospital, Stockholm, Sweden
22Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
23Hospital Universitario "Virgen de las Nieves", Granada, Spain
24Southampton Univ. Hospitals, Southampton, GBR
25ICO Duran i Reynals, BARCELONA, Spain
26Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
27Hospital Clinic, Dept. of Hematology, IDIBAPS, Barcelona, Spain, Barcelona, Spain
28Nijmegen Medical Centre, Nijmegen, Netherlands
29Clinical Hematology, Strasbourg University Hospital, Strasbourg, France
30Hospital Universitario La Paz, Madrid, ESP
31Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
32Hematology Unit and CTMO, G. da Saliceto Hospital, Piacenza, ITA
33Adult Hematopoietic Stem Cell Transplantation Unit, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey
34Department of Hematology Transplantation, St-Louis Hospital, APHP, Bone Marrow, Paris, France
35EBMT Data Office, Leiden, Netherlands
36Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular (GETH), Madrid, Spain
37University Hospital Eppendorf, Hamburg, Germany
38Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
39Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

Brian D Friend, MD1, Larisa Broglie, MD, MS2*, Brent Logan, PhD3,4*, Caitrin Fretham, MPH5*, Gary J. Schiller, MD6, Bipin N. Savani, MD7, Edward Stadtmauer8*, Saurabh Chhabra, MD, MS9, Marcelo C. Pasquini, MD, MS10, Monica Thakar, MD11 and Mohamed Sorror, MD, MSc12*

1Texas Medical Center, Houston, TX
2Columbia University, New York, NY
3Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
4Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5National Marrow Donor Program/Be The Match, Minneapolis, MN
6David Geffen School of Medicine at University of California, Los Angeles, CA
7Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN
8University of Pennsylvania, Philadelphia, PA
9Division of Hematology/Oncology, Department of Medicine, Medical College of Wiscosin, Milwaukee, WI
10CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
11Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA
12Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Mohamad Mohty, MD, PhD1, Ibrahim Yakoub-Agha2, Myriam Labopin, MD1*, Didier Blaise, MD3, Delphine Lebon, MD4*, Virginie Gandemer, MD, PhD5*, Sébastien Maury6*, Cecile Renard7*, Charlotte Jubert8*, Robert J. Ryan9*, Virginie Bouvatier10*, Jean-Hugues Dalle, MD, PhD11* and Regis Peffault De Latour, MD, PhD12*

1Hôpital St Antoine, Sorbonne University, INSERM UMRs 938, Paris, France
2CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000 Lille, France
3Institut Paoli-Calmettes, Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France
4CHU Amiens Picardie Hôpital, Amiens, France
5University Hospital of Rennes, Rennes, France
6Hôpital Henri Mondor, Université Paris-Est Créteil Val de Marne (UPEC), Créteil, France
7Institute of Pediatric Hematology and Oncology, Lyon, France
8Hôpital des Enfants, Bordeaux, France
9Jazz Pharmaceuticals, Philadelphia, PA
10Jazz Pharmaceuticals, Lyon, France
11Hôpital Robert-Debré, GHU APHP Nord and University of Paris, Paris, France
12Hôpital Saint-Louis, Paris, France

Rebecca A. Marsh1*, Soyoung Kim2*, Kyle Hebert3*, Christopher C. Dvorak, MD4, Victor Aquino, MD5, K. Scott Scott Baker, MD, MS6, Deepak Chellapandian, MD7*, Blachy Davila, MD8*, Christine Duncan, MD9, Michael J. Eckrich, MD, MPH10, George E. Georges, MD11*, Timothy S. Olson, MD, PhD12, Michael A Pulsipher, MD13, Shalini Shenoy, MD14, Elizabeth Stenger, MD15, Mark Vander Lugt, MD16*, Lolie C. Yu, MD17, Andrew Gennery, MD18* and Mary Eapen, MBBS, MS19

1Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3CIBMTR and Medical College of Wisconsin, Milwaukee, WI
4Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA
5UT Southwestern Medical Center, Dallas, TX
6Fred Hutchinson Cancer Research Ctr., Seattle, WA
7Johns Hopkins All Children's Hospital, St Petersburg, FL
8BMT, Children's National Medical Center, Washington, DC
9Dana-Farber Cancer Institute, Boston, MA
10Pediatric Blood and Marrow Transplantation Program, Texas Transplant Institute at Medical City Dallas, San Antonio, TX
11Fred Hutchinson Cancer Research Center, Seattle, WA
12Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
13Children's Hospital of Los Angeles, Los Angeles, CA
14Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
15Children's Hospital of Pittsburgh, Pittsburgh, PA
16The University of Michigan, Ann Arbor, MI
17Children's Hospital, New Orleans, LA
18Newcastle University, Newcastle Upon Tyne, United Kingdom
19CIBMTR department of Medicine, Medical College of Wisconsin, Milwaukee, WI

*signifies non-member of ASH